Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 32, 2006 - Issue 10
Submit an article Journal homepage
296
Views
38
CrossRef citations to date
0
Altmetric
Research Article

D-Optimal Mixture Design: Optimization of Ternary Matrix Blends for Controlled Zero-Order Drug Release From Oral Dosage Forms

Yasser El-Malah Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, 71209-0497, USA
,
Sami Nazzal Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, 71209-0497, USA
&
Nile M. Khanfar College of Pharmacy, Department for Pharmaceutical and Administration Sciences, Nova Southeastern University, Palm Beach Gardens, FL, 33410, USA
Pages 1207-1218 | Published online: 25 Sep 2008

REFERENCES

  • Bloomfield M. S., Butler W. C. Robustness testing, using experimental design of a flow-through dissolution method for a product where the actives have markedly differing solubility properties. Int. J. Pharm. 2000; 206: 55–61, [INFOTRIEVE], [CSA]
  • Bolton S. Pharmaceutical Statistics: Practical and Clinical Application2nd. Informa UK Ltd, New York 1990, Revised and Expanded
  • Busse W. W., Lemanske R. F. Asthma. N. Engl. J. Med. 2001; 344: 350–362, [INFOTRIEVE], [CSA], [CROSSREF]
  • Center for Drug Evaluation and Research (CDER). Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Informa UK Ltd, Rockville, MD 1997
  • Fan L. T., Singh S. K. Controlled Release. Informa UK Ltd, Berlin 1989
  • Gao P., Witt M. J., Haskell R. J., Zamora K. M., Shifflett J. R. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm. Dev. Technol. 2004; 9: 1–9, [CSA], [CROSSREF]
  • Hansel T. T., Tennant R. C., Tan A. J., Higgins L. A., Neighbour H., Erin E. M., Barnes P. J. Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease. Drugs of Today 2004; 40: 55–69, [INFOTRIEVE], [CSA], [CROSSREF]
  • Jantzen G. M., Robinson J. R. Sustained and Controlled-Release Drug-Delivery System. Modern Pharmaceutics, G. S. Banker, C. T. Rhodes. Informa UK Ltd, New York 2002; 501–528
  • Ju R. T. C., Nixon P. R., Patel M. V. Diffusion coefficient of polymer chains in the diffusion layer adjacent to a swollen hydrophilic matrix. J. Pharm. Sci. 1997; 86: 1293–1298, [INFOTRIEVE], [CSA], [CROSSREF]
  • Ju R. T. C., Nixon P. R., Patel M. V., Tong D. M. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J. Pharm. Sci. 1995; 84: 1464–1477, [INFOTRIEVE], [CSA], [CROSSREF]
  • Jumaa M., Kleinebudde P., Muller B. W. Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers. Pharm. Acta Helv. 1999; 73: 293–301, [CSA], [CROSSREF]
  • Kim C. J. Drug Release from Compressed Hydrophilic POLYOX-WSR Tablets. J. Pharm. Sci. 1994; 84: 303–306, [CSA], [CROSSREF]
  • Kim H., Fassihi A. R. Application of a binary polymer system in drug release rate modulation: 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci. 1997; 86: 323–328, [INFOTRIEVE], [CSA], [CROSSREF]
  • Kincl M., Vrecer F., Veber M. Characterization of factors affecting the release of low solubility drug from prolonged release tablets. Anal. Chim. Acta 2004; 502: 107–113, [CSA], [CROSSREF]
  • Korsmeyer R. W., Gurney R., Doelker E., Buri P., Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25–35, [CSA], [CROSSREF]
  • Lee L. Diffusion-controlled matrix system. Treatise on Controlled Drug Delivery, A. Kydonieus. Informa UK Ltd, New York 1992; 155–198
  • Lyman D. J., Kim S. W. Aqueous diffusion through partition membranes. J. Polym. Sci.: Polym. Symp. 1973; 41: 139–144, [CSA]
  • Mannino D. M., Homa D. M., Pertwski C. A. Surveillance for asthma—United States, 1960–1995. MMWR CDC Surveil. Summ. 1998; 47: 1–27, [CSA]
  • Moore J. W., Flanner H. H. Mathematical comparison of dissolution profiles. Pharm. Tech. 1996; 20: 64–74, [CSA]
  • Nazzal S., Nutan M., Palamakula A., Shah R., Zaghloul A. A., Khan M. A. Optimization of a self-emulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int. J. Pharm. 2002; 240: 103–114, [INFOTRIEVE], [CSA], [CROSSREF]
  • Parojcic J., Duric Z., Jovanovic M., Ibric S., Nicolic L. Influence of pH and agitation intensity on drug dissolution from tablets evaluated by means of factorial design. Pharm. Ind. 2001; 63: 774–779, [CSA]
  • Peppas N. A. Hydrogels in Medicine and Pharmacy, Vols. I, II and III. Informa UK Ltd, Boca Raton, FL 1998
  • Peppas N. A., Sinclair J. L. Anomalous transport of penetrants in glassy polymers. Colloid Polymer Sci. 1983; 261: 404–408, [CSA], [CROSSREF]
  • Reilly W. J. Pharmaceutical necessities. Remington's Pharmaceutical Science21st, A. R. Genarro. Informa UK Ltd, Easton, PA 2005; 1058–1092
  • Sastry A. V., Khan M. A. Aqueous-based polymeric dispersion: face-centered cubic design for the development of atenolol gastrointestinal therapeutic system. Pharm. Dev. Technol. 1998; 3: 423–432, [INFOTRIEVE], [CSA]
  • Shah V. P., Tsong Y., Sathe P., Liu J. In vitro dissolution profiles comparison-statistics and analysis of the similarity factor f2. Pharm. Res. 1998; 15: 889–896, [INFOTRIEVE], [CSA], [CROSSREF]
  • Siepmann J., Streubel A., Peppas N.A. Understanding and prediction drug delivery from hydrophilic matrix tablets using the sequential layer model. Pharm. Res. 2002; 19: 306–313, [INFOTRIEVE], [CSA], [CROSSREF]
  • Yang L., Fassihi R. Zero-order release kinetics from a self-correcting floatable asymmetric configuration drug delivery system. J. Pharm. Sci. 1996; 85: 170–173, [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.